본문으로 건너뛰기
← 뒤로

Botulinum toxin type A as a novel method of preventing cleft lip scar hypertrophy-A literature review.

Journal of cosmetic dermatology 2020 Vol.19(9) p. 2188-2193

Bartkowska P, Roszak J, Ostrowski H, Komisarek O

관련 도메인

📝 환자 설명용 한 줄

[BACKGROUND] Cleft lip is a congenital development defect.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Bartkowska P, Roszak J, et al. (2020). Botulinum toxin type A as a novel method of preventing cleft lip scar hypertrophy-A literature review.. Journal of cosmetic dermatology, 19(9), 2188-2193. https://doi.org/10.1111/jocd.13614
MLA Bartkowska P, et al.. "Botulinum toxin type A as a novel method of preventing cleft lip scar hypertrophy-A literature review.." Journal of cosmetic dermatology, vol. 19, no. 9, 2020, pp. 2188-2193.
PMID 32654297
DOI 10.1111/jocd.13614

Abstract

[BACKGROUND] Cleft lip is a congenital development defect. Primary cleft lip repair leads to cleft scar formation. The resulting scar often undergoes hypertrophy, which negatively affects the facial esthetics, function, and patient's mental health. One of the methods used in scar therapy described in recent years is botulinum toxin injections The aim of this work is to present current knowledge about the impact of botulinum toxin A on cleft lip scar appearance and its effect on scar hypertrophy.

[METHODS] The literature search was conducted in the English language via the PubMed and Google Scholar databases.

[RESULTS] The results show injections seem to be a promising method in cleft lip scar management. However, future studies, especially randomized controlled trials, are necessary to assess the effect of BoNT-A compared with placebo and to determine the optimal dosages and injection schemes for BoNT-A treatment in cleft lip patients.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 botulinum toxin 보툴리눔독소 주사 dict 3

MeSH Terms

Botulinum Toxins, Type A; Cicatrix; Cleft Lip; Humans; Hypertrophy; Lip

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문